How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure

Abstract

Though antihypertensive drugs have been in use for many decades, the mechanisms by which they act chronically to reduce blood pressure remain unclear. Over long periods, mean arterial blood pressure must match the perfusion pressure necessary for the kidney to achieve its role in eliminating the daily intake of salt and water. It follows that the kidney is the most likely target for the action of most effective antihypertensive agents used chronically in clinical practice today. Here we review the long-term renal actions of antihypertensive agents in human studies and find three different mechanisms of action for the drugs investigated. (i) Selective vasodilatation of the renal afferent arteriole (prazosin, indoramin, clonidine, moxonidine, α-methyldopa, some Ca++-channel blockers, angiotensin-receptor blockers, atenolol, metoprolol, bisoprolol, labetolol, hydrochlorothiazide, and furosemide). (ii) Inhibition of tubular solute reabsorption (propranolol, nadolol, oxprenolol, and indapamide). (iii) A combination of these first two mechanisms (amlodipine, nifedipine and ACE-inhibitors). These findings provide insights into the actions of antihypertensive drugs, and challenge misconceptions about the mechanisms underlying the therapeutic efficacy of many of the agents.

Dynamic tissue perfusion assessment reflects associations between antihypertensive treatment and renal cortical perfusion in patients with chronic kidney disease and hypertension

“…In the present study, we demonstrated a significant independent association of renal perfusion parameters assessed by DTPM with the type of antihypertensive drugs. The correlations demonstrated in our work correspond with current knowledge based on invasive methods [ 19 ]. The drugs blocking the activity of angiotensin II (ACE-I, ARB) preferentially dilate the efferent arteriole in renal glomerulus and thus decrease renal vascular resistance (RVR), reduce intraglomerular capillary pressure and increase renal blood flow.…”

The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model

“…Prazosin is an antagonist at the alpha-1 class sub-types of adrenergic receptors. Prazosin hydrocloride capsules are indicated for the treatment of hypertension, to lower blood pressure [40,41]. The drug has later been reported to reduce nightmares in PTSD.…”

Stroke volume and proteinuria in obesity‐related glomerulopathy: potential role in pathogenesis and choice of antihypertensive regimen

“…12 This can be supported by the fact that the use of diuretics or β-blockers is associated with a decrease in cardiac output. 13 Moreover, an experimental study showed that low doses of the sympatholytic drug moxonidine that failed to affect blood pressure in rats by telemetry signifi-…”